Advanced in Spinal Tumor

Dr. Jeffrey N. Bruce

Neurosurgery
Trustees Of Columbia University In The City Of New York
622 W 168th St, 
New York, NY 
Offers Telehealth
Advanced in Spinal Tumor
Trustees Of Columbia University In The City Of New York
622 W 168th St, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jeffrey Bruce is a Neurosurgery provider in New York, New York. Dr. Bruce is rated as an Advanced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Gamma Knife Radiosurgery, and Awake Craniotomy.

His clinical research consists of co-authoring 251 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Spinal Tumor.

Specialties
Neurosurgery
Licenses
Neurological Surgery in NY
Hospital Affiliations
New York-Presbyterian Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
622 W 168th St, New York, NY 10032

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
Enrollment Status: Terminated
Publish Date: January 24, 2025
Intervention Type: Biological, Drug
Study Drugs: HSPPC-96, Bevacizumab
Study Phase: Phase 2
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Enrollment Status: Completed
Publish Date: June 25, 2024
Intervention Type: Radiation, Procedure
A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration Positive Patients With Stage IV Squamous Cell Lung Cancer (Lung-Map Sub-Study)
A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration Positive Patients With Stage IV Squamous Cell Lung Cancer (Lung-Map Sub-Study)
Enrollment Status: Completed
Publish Date: May 27, 2021
Intervention Type: Other, Drug
Study Drugs: Docetaxel, Palbociclib
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

250 Total Publications

Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.
Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 07, 2025
Similar Doctors
Distinguished in Spinal Tumor
Dr. Daniel M. Sciubba
Neurosurgery | Neurology
Distinguished in Spinal Tumor
Dr. Daniel M. Sciubba
Neurosurgery | Neurology

North Shore-Lij Medical PC

27005 76th Ave, 
New Hyde Park, NY 
 (13.7 miles away)
718-470-7000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniel Sciubba is a Neurosurgery specialist and a Neurologist in New Hyde Park, New York. Dr. Sciubba is rated as an Elite provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Chordoma, Scoliosis, Bone Tumor, Osteotomy, and Spinal Fusion.

Distinguished in Spinal Tumor
Dr. Aladine A. Elsamadicy
Neurosurgery
Distinguished in Spinal Tumor
Dr. Aladine A. Elsamadicy
Neurosurgery

North Shore-Lij Medical PC

444 Merrick Rd, Suite 106a, 
Lynbrook, NY 
 (18.7 miles away)
516-550-2191
Languages Spoken:
English

Aladine Elsamadicy is a Neurosurgery provider in Lynbrook, New York. Dr. Elsamadicy is rated as a Distinguished provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Spinal Tumor, Adolescent Idiopathic Scoliosis, Cervical Spondylosis, Spinal Fusion, and Laminectomy.

Distinguished in Spinal Tumor
Dr. Mark Bilsky
Neurosurgery
Distinguished in Spinal Tumor
Dr. Mark Bilsky
Neurosurgery

Mskcc Surgery Group

1275 York Ave, 
New York, NY 
 (5.4 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Bilsky is a Neurosurgery provider in New York, New York. Dr. Bilsky is rated as a Distinguished provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Chordoma, Bone Tumor, Spinal Tumor, Vertebroplasty, and Laminectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bruce's expertise for a condition
ConditionClose
View All 20 Distinguished Conditions
View All 12 Advanced Conditions
View All 27 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile